Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium spp. heme detoxification pathway is a critical survival mechanism for malaria parasites during their intraerythrocytic stage. As the parasite digests host hemoglobin to obtain essential amino acids, it releases large amounts of toxic free heme, specifically ferriprotoporphyrin IX (Egan, 2008, Drug Design Reviews). To prevent cellular damage, the parasite detoxifies this heme by sequestering it into an insoluble, chemically inert crystalline form known as hemozoin or malaria pigment (Sullivan, 2002, International Journal for Parasitology). This biocrystallization process occurs primarily within the acidic digestive vacuole and is facilitated by parasite-encoded proteins like Heme Detoxification Protein (HDP) and various lipids (Jani et al., 2008, PLoS Pathogens). This pathway is the primary target for several classes of antimalarial drugs, most notably the 4-aminoquinolines like chloroquine, which bind to heme and prevent its incorporation into the growing hemozoin crystal (Combrinck et al., 2013, ACS Chemical Biology). The resulting buildup of free heme is lethal to the parasite, making this pathway one of the most successful targets in the history of antimalarial chemotherapy.
Inhibition of the conversion of toxic free heme (ferriprotoporphyrin IX) into non-toxic, crystalline hemozoin within the parasite's digestive vacuole, leading to heme-mediated membrane damage and parasite death (Sullivan et al., 1996, Science).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium spp. heme detoxification pathway.